Clinical Trial Update: To Evaluate Recombinant Human Follicle Stimulating Hormone-CTP Fusion Protein Injection or Placebo Combined With Chorionic Gonadotropin for Injection [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a recombinant human FSH-CTP fusion protein with chorionic gonadotropin versus placebo for idiopathic hypogonadotropic hypogonadism; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Hypogonadotropic Hypogonadism

Drugs mentioned

• Chorionic gonadotropin (human chorionic gonadotropin)
• Recombinant human FSH-CTP fusion protein (recombinant human follicle-stimulating hormone-CTP fusion protein)

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Idiopathic Hypogonadotropic Hypogonadism | Phase 3 | Status: NOT_YET_RECRUITING